A single-center experience in the management of Altemeier-Klatskin tumors

Journal of Gastrointestinal and Liver Diseases

Volumn 16, Issue 4, 2007, Pages 383-389

  Tsalis, Konstantinos ^a   Vasiliadis, Konstantinos ^a,b   Kalpakidis, Vasilios ^a   Christoforidis, Emmanuel ^a   Avgerinos, Antonios ^a   Botsios, Dimitrios ^a   Megalopoulos, Angelos ^a   Haidich, Anna Bettina ^a   Betsis, Dimitrios ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b NONE   (Greece)

Author keywords

Hepatectomy; Hilar cholangiocarcinoma; Intrahepatic anastomosis; Klatskin tumor

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER CHEMOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHOLEDOCHOJEJUNOSTOMY; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HUMAN; KLATSKIN TUMOR; LIVER RESECTION; MALE; MORBIDITY;

ADULT; AGED; AGED, 80 AND OVER; ANASTOMOSIS, SURGICAL; BILE DUCT NEOPLASMS; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HEPATIC DUCT, COMMON; HUMANS; KAPLAN-MEIERS ESTIMATE; KLATSKIN'S TUMOR; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 37549027246     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Altemeier WA, Gall EA, Zinninger MM, Hoxworth PI. Sclerosing carcinoma of the major intrahepatic bile ducts. Arch Surg 1957; 75:459-461.
2. Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med 1965; 38:241-256.
3. Launois B, Terblanche J, Lakehal M, et al. Proximal bile duct cancer: high resectability rate and 5-year survival. Ann Surg 1999; 230:266-275.
4. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992, 215: 31-38.
5. Launois B, Wemyss-Holden S, Maddern GJ. Current and future trends in management and treatment of Klatskin tumour. Int J Clin Oncol 2002; 7:91-102.
6. Singhal D, van Gulik TM, Gouma DJ. Palliative management of hilar cholangiocarcinoma. Surg Oncol 2005; 14:59-74.
7. Neuhaus P, Jonas S, Bechstein WO, et al. Extended resections for hilar cholangiocarcinoma. Ann Surg 1999; 230:808-819.
8. Kosuge T, Yamamoto J, Shimada K, Yamasaki S, Makuuchi M. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 1999; 230:663-671.
9. Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001; 234:507-519.
10. Iwatsuki S, Todo S, Marsh JW, et al. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation, J Am Coll Surg 1998; 187:358-364.
11. Miyazaki M, Ito H, Nakagawa K, et al. Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection? Surgery 1998, 123:131-136.
12. Capussotti L, Muratore A, Polastri R, Ferrero A, Massucco P. Liver resection for hilar cholangiocarcinoma: in-hospital mortality and longterm survival. J Am Coll Surg 2002; 195:641-647.
13. Madariaga JR, Iwatsuki S, Todo S, Lee RG, Irish W, Starzl TE. Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg 1998; 227: 70-79.
14. Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 1975; 140:170-178.
15. American Joint Committee on Cancer. Extrahepatic bile ducts. In: Greene FL, eds. American Joint Committee on Cancer: AJCC Cancer Staging Handbook. New York: Springer; 2002:163-169.
16. Burke EC, Jarnagin WR, Hochwald SN, Pisters PW, Fong Y, Blumgard LH. Hilar cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg 1998, 228:385-394.
17. Manfredi R, Barbaro B, Masselli G, Vecchioli A, Marano P. Magnetic resonance imaging of cholangiocarcinoma. Semin Liver Dis 2004; 24: 155-164.
18. Jarnagin WR, Saldinger PF, Blumgart LH. Cancer of the bile ducts: the hepatic ducts and common bile duct. In Blumgart LH, Fong Y eds. Surgery of the liver and biliary tract, 3rd ed. WB Saunders Co,Philadelphia 2000, Vol I: 1017-1040.
19. Launois B, Jamieson GG. The posterior intrahepatic approach for hepatectomy or removal of segments of the liver. Surg Gynecol Obstet 1992, 174:155-158.
20. Launois B, Jamieson G. Modern operative techniques in liver surgery. Churchill Livingstone Edinburgh 1993: 23-36.
21. Ahrendt SA, Nakeeb A, Pitt HA. Cholangiocarcinoma. Clin Liver Dis 2001; 5:191-218.
22. Zervos E, Pearson H, Durkin AJ, et al. In-continuity hepatic resection for advanced hilar cholangiocarcinoma. Am J Surg 2004; 188:584-588.
23. Launois B, Reding R, Lebeau G, Buard JL. Surgery for hilar cholangiocarcinoma: French experience in a collective survey of 552 extrahepatic bile duct cancers. J Hepatobiliary Pancreat Surg 2000; 7:128-134.
24. Ogura Y, Kawarada Y. Surgical strategies for carcinoma of the hepatic duct confluence. Br J Surg 1998; 85:20-24.
25. Mizumoto R, Kawarada Y, Suzuki H. Surgical treatment of hilar carcinoma of the bile duct. Surg Gynecol Obstet 1986; 162:153-158.
26. Kawasaki S, Imamura H, Kobayashi A, Noike T, Miwa S, Miyagawa S. Results of surgical resection for patients with hilar bile duct cancer, application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg 2003; 238: 84-92.
27. Melendez J, Ferri E, Zwillman M, et al. Extended hepatic resection: a 6-year retrospective study of risk factors for perioperative mortality. J Am Coll Surg 2001; 192:47-53.
28. Imamura H, Seyama Y, Kokudo N, et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 2003; 138:1198-1206.
29. Seyama Y, Kubota K, Sano K, et al. Long-term outcome of exten-ded hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg 2003; 238:73-83.
30. Nimura Y, Kamiya J, Kondo S, et al. Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat Surg 2000; 7:155-162.
31. Rea DJ, Munoz-Juarez M, Farnell MB, et al. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients. Arch Surg 2004; 139: 514-523.
32. Tannapfel A, Weinans L, Geissler F, et al. Mutations of p53 tumor suppressor gene, apoptosis, and proliferation in intrahepatic cholangiocellular carcinoma of the liver. Dig Dis Sci 2000; 45:317-324.
33. Dinant S, Gerhards MF, Rauws EA, Busch OR, Gouma DJ, van Gulik TM. Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor). Ann Surg Oncol 2006; 13:872-880.
34. Roayaie S, Guarrera J, Ye MQ, et al. Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes. J Am Coll Surg 1998; 187:365-372.
35. Leung J, Guiney M, Das R. Intraluminal brachytherapy in bile duct carcinomas. Aust N Z J Surg 1996; 66:74-77.
36. Lees CD, Zapolanski A, Cooperman AM, Herman RE. Carcinoma of the bile ducts. Surg Gynecol Obstet 1980; 151: 193-198.
37. Pitt HA, Nakeeb A, Abrams RA, et al. Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Ann Surg 1995; 221:788-797.
38. Todoroki T, Ohara K, Kawamoto T, et al. Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma. Int J Radiat Oncol Biol Phys 2000; 46:581-587.